UNSPSC 51162713: Guaiacol

This classification denotes an anti-infective agent and expectorant with the molecular formula C7H8O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6JKA7MAH9C, chemically known as phenol, o-methoxy- but more generally known as guaiacol, which bears US NIH Compound Identifier 460. European Medicines Agency schedules Guaiacol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14027MIG. Most nations, for tariff and trade purposes, schedule guaiacol under HS 29095000 and SITC 51617.

As of Q4 2014, GUAIACOL remains US FDA's Preferred Term for this commodity. Guaiacol bears US NLM identifiers UMLS ID C0018304 and NCI Concept Code C76663. SMILES: O(C1C(O)CCCC1)C.

UNSPSC 51162713 Guaiacol, a Commodity code, does not align with the state and local opportunities currently tagged under it. The recent solicitations target naloxone and drug deactivation systems (Seminole County, Florida) and generic pharmaceuticals and over-the-counter products through a multistate cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance), neither of which relate to guaiacol, a chemical compound used primarily in industrial and specialty applications. The mismatch suggests either miscoding in the underlying procurement databases or a fundamental disconnect between the code's nominal scope and current transactional activity.

The two opportunities on file show activity from a county health department (Seminole County) and a state-administered cooperative purchasing program (MMCAP, covering Minnesota and participating jurisdictions including Oregon), but neither procurement involves guaiacol or products within that chemical family. Without recent state and local opportunities that actually align with the code's intended scope, this Commodity code shows no actionable market signal for vendors in the guaiacol supply chain at this time.